Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 9Recruiting 3Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 13Specimen Handling 12Radiotherapy 12Androgen Antagonists 12Magnetic Resonance Spectroscopy 10Nivolumab 9pembrolizumab 8darolutamide 7Drug Therapy 7toripalimab 6Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Ipilimumab 4Cyclophosphamide 4Biopsy 4Axitinib 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × 5-aminolevulinic acid hexyl ester × Genitourinary × Clear all
NCT06548438 2024-08-12

TUR_BLUE

A.O.U. Città della Salute e della Scienza

Phase 4 Not yet recruiting
300 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡